India is in the middle of a diabetes wave that has been building for three decades, and women are carrying a disproportionate share of it. The national prevalence of type 2 diabetes in adult women is now around ten percent, with substantial state-by-state and urban-rural variation. Urban Indian women in the metros tend to have higher rates than rural women, although rural prevalence is rising fast. The age of onset has also been falling: where type 2 diabetes was once a disease of late middle age, it is now routinely diagnosed in women in their thirties and forties, and a small but growing share of cases are diagnosed in women under thirty.

Two facts give the Indian picture its specific shape. The first is the South Asian genetic susceptibility — for any given body mass index, a South Asian woman carries about five times the type 2 diabetes risk of a Caucasian woman of the same weight. This is partly explained by body composition: South Asian women tend to carry more visceral fat (the deep abdominal fat around the organs) at a lower overall body weight, a pattern sometimes called the thin-fat Indian phenotype. The second is the layering of female-specific risk factors on top of this genetic baseline: PCOS, gestational diabetes history, menopause-related insulin sensitivity changes, sedentary urban work patterns and chronic stress all push the lifetime risk higher.

The good news is that this is one of the most studied conditions in the world, the medications are widely available and affordable in India, and the lifestyle changes that work are well within reach for most Indian families. The bad news is that diabetes in India is often diagnosed late, sometimes only after a complication has already developed, because early symptoms in women can be very subtle and are easily mistaken for everyday tiredness.

Type 1 diabetes is an autoimmune condition in which the body's own immune system destroys the insulin-producing beta cells in the pancreas. As a result, the pancreas can no longer make insulin, and the person needs insulin from outside the body to survive. It accounts for about five to ten percent of all diabetes, typically appears in childhood or young adulthood (though it can present at any age), and is not caused by lifestyle. Onset can be quite sudden, with classic symptoms of excessive thirst, frequent urination, weight loss and fatigue developing over weeks rather than years. Insulin therapy is needed from the day of diagnosis and continues lifelong.

Type 2 diabetes is a condition of insulin resistance, in which the pancreas still makes insulin but the body's tissues cannot use it efficiently. Over time, the pancreas struggles to keep up with the higher demand and begins to fail. Type 2 accounts for about ninety percent of all diabetes worldwide, usually appears in middle age and beyond, and is strongly shaped by genetics combined with body composition, diet and lifestyle. Onset is gradual, and symptoms may be absent or subtle for years before diagnosis. Treatment usually begins with lifestyle changes and metformin, with additional medications added in steps as needed.

Gestational diabetes (GDM) is high blood sugar that appears for the first time in pregnancy and resolves after delivery. It is important not only for the immediate pregnancy but because about half of women with GDM go on to develop type 2 diabetes within ten years. MODY (maturity-onset diabetes of the young) is a rare genetic form of diabetes that runs strongly in families and typically appears before age twenty-five. LADA (latent autoimmune diabetes in adults) is a slow-onset autoimmune form that looks like type 2 at first but behaves more like type 1 over time.

Indian women face a stack of risk factors for type 2 diabetes that are not all shared by women in other populations, and understanding this stack is the starting point for prevention. The first layer is genetic — South Asian populations have a higher inherited susceptibility to insulin resistance and type 2 diabetes, with relative risks about five times those of Caucasian populations at the same body mass index. The second layer is body composition — South Asian women tend to carry more visceral fat at a lower overall weight, the thin-fat phenotype, which means a woman with a body mass index of twenty-three may already have metabolic features more typical of a heavier woman from another population.

The third layer is diet — the traditional Indian plate is heavy in refined carbohydrates (white rice, refined wheat roti, suji, maida, sweetened chai) and lighter in fibre, lean protein and vegetables than is ideal for metabolic health. The fourth layer is the female-hormonal stack — PCOS raises type 2 diabetes risk by three to seven times, gestational diabetes raises lifetime type 2 diabetes risk substantially, and the perimenopause and menopause transition reduces insulin sensitivity even further. For a deeper look at the PCOS dimension, see PCOS Isn’t Your Fault: Understanding, Managing & Thriving and Anti‑PCOS Diet – What Actually Works.

The fifth layer is the lifestyle reality of modern urban India — long sedentary office hours, long commutes, less walking than a generation ago, and chronic stress with elevated cortisol that worsens insulin resistance. The sixth is sleep — Indian women, especially in roles that combine paid work with caregiving, are often sleep-deprived, and short sleep itself worsens glucose handling. Each of these layers alone is a modest risk; stacked together, they produce the very high lifetime risk of type 2 diabetes that Indian women now carry, and they also point to where intervention has the most leverage.

The classic symptoms of high blood sugar are easy to remember as the three Ps — polyuria (frequent urination), polydipsia (excessive thirst) and polyphagia (excessive hunger) — usually with unexplained weight loss in type 1 and sometimes in poorly controlled type 2. Add fatigue, blurred vision, slow-healing wounds, frequent infections, numbness or tingling in the hands and feet, and dark velvety patches on the neck and armpits (acanthosis nigricans, which often signals insulin resistance even before frank diabetes), and you have the standard symptom checklist.

In women, however, several extra clues are easy to miss because they look like everyday gynaecological problems. Recurrent yeast infections (especially candidiasis with itching, discharge and discomfort) can be the first sign that blood sugar is too high. Recurrent urinary tract infections — more than two or three episodes in a year — should always prompt a fasting glucose and HbA1c check. Irregular periods, especially in the context of PCOS, often coexist with insulin resistance and pre-diabetes. Reduced libido and decreased vaginal lubrication can also appear with poorly controlled diabetes. For the UTI angle specifically and how to investigate recurrent infections, see recurrent-uti-india.

Type 1 onset in young women can be more dramatic — over a few weeks, weight drops despite eating well, thirst becomes constant, urination is frequent including at night, and fatigue is profound. If a young woman develops fruity-smelling breath, vomiting, abdominal pain and confusion, this can be diabetic ketoacidosis and is a medical emergency that needs immediate hospital care. Type 2 onset, by contrast, is often silent for years, which is why opportunistic screening at routine health check-ups is so important for any Indian woman over thirty, or earlier with risk factors.

Four tests sit at the centre of diabetes diagnosis, and they are all readily available across India in both government facilities and private lab networks such as Thyrocare, Metropolis, SRL and Dr Lal PathLabs. Fasting plasma glucose, drawn after at least eight hours without food, diagnoses diabetes at a level of one hundred and twenty-six milligrams per decilitre or higher on two separate occasions. The pre-diabetes range is one hundred to one hundred twenty-five. The fasting glucose test costs roughly fifty to two hundred rupees in private labs and is often free at government facilities.

Random plasma glucose, drawn at any time without regard to meals, diagnoses diabetes at a level of two hundred milligrams per decilitre or higher when classic symptoms (thirst, frequent urination, weight loss) are also present. HbA1c, which reflects the average blood sugar over the previous three months, diagnoses diabetes at a level of six point five percent or higher. The pre-diabetes range is five point seven to six point four. HbA1c is the most useful single test for both diagnosis and monitoring because it is not affected by what was eaten the previous day, and it costs about two hundred and fifty to eight hundred rupees in private labs.

The oral glucose tolerance test (OGTT) uses a seventy-five gram glucose drink, with blood drawn fasting and at two hours, and diagnoses diabetes at a two-hour level of two hundred milligrams per decilitre or higher. The OGTT is the standard test for gestational diabetes and is useful when fasting glucose is borderline and HbA1c is in the pre-diabetes range. It costs about five hundred to fifteen hundred rupees. Most Indian women with suspected diabetes are diagnosed using a combination of HbA1c and fasting glucose, with the OGTT reserved for pregnancy or unclear cases.

Pre-diabetes is the warning zone in which blood sugar is higher than normal but not yet in the diabetes range — fasting glucose of one hundred to one hundred twenty-five milligrams per decilitre, or HbA1c of five point seven to six point four percent. It is not a benign finding. Without intervention, roughly seventy percent of people with pre-diabetes progress to type 2 diabetes within ten years, often much sooner in South Asian women given the underlying genetic susceptibility. But the same finding viewed differently is the most reversible stage of the entire diabetes journey — the stage at which diet, weight loss and exercise can return blood sugar to normal in a large share of people and substantially delay or prevent the onset of full diabetes.

Indian women in the pre-diabetes range should treat it as a serious wake-up call rather than a minor abnormality. The interventions that work are the same lifestyle changes that work for established type 2 diabetes — replacing refined carbohydrates with high-fibre complex carbohydrates (millets, brown rice, multigrain atta), increasing the vegetable share of the plate to half, adding regular physical activity of at least one hundred and fifty minutes per week, building in resistance training twice a week, improving sleep, and managing stress. Modest weight loss of five to seven percent of body weight has been shown in many studies to substantially reduce diabetes risk.

Pre-diabetes is also the right moment to address the upstream conditions that often coexist with it — PCOS, hypothyroidism, sleep disturbance, depression and anxiety — because untreating any of them makes the diabetes prevention task harder. A repeat HbA1c every six to twelve months tracks whether the changes are working and provides the motivation to keep going.

The single biggest dietary change that helps Indian women with pre-diabetes or type 2 diabetes is shifting away from refined carbohydrates and toward complex high-fibre carbohydrates with a lower glycaemic index. White rice, refined wheat roti, maida, suji, naan and bread spike blood sugar quickly and steeply. Replacing them with finger millet (ragi), pearl millet (bajra), sorghum (jowar), foxtail millet, brown rice, hand-pounded rice and multigrain atta provides slower-release energy that the body handles much more smoothly. Quinoa and rolled oats are also useful additions, though they are imports and more expensive.

The second principle is the plate composition. Half the plate should be non-starchy vegetables, especially leafy greens such as palak, methi, sarson and amaranth, plus seasonal sabzi from bottle gourd, ridge gourd, snake gourd, bhindi and cauliflower. A quarter of the plate is the complex-carbohydrate share — a portion of millet roti, brown rice or a small serving of unrefined whole grains. The remaining quarter is the protein share — dal, sprouts, paneer, eggs, and for non-vegetarian families fish or chicken — which slows down the glucose response and supports satiety. Healthy fats from ghee in moderation, nuts, seeds, mustard or olive oil round out the meal.

What to avoid is as important as what to add. Mithai, sugar in chai, biscuits, bakery products, fried snacks like samosa and pakora, processed packaged snacks, sweetened soft drinks and juices, and white bread all need to step back from the daily routine. Whole fruit in moderation is fine — apple, pear, papaya, guava, jamun, berries are good choices and the fibre slows down sugar absorption. Hydration with about three litres of water a day, avoiding sweetened beverages, also matters. For the closely related PCOS-specific diet that overlaps substantially with the diabetes diet, see Anti‑PCOS Diet – What Actually Works.

Physical activity is one of the two most powerful diabetes interventions, equal in some ways to medication. The standard recommendation is at least one hundred and fifty minutes of moderate-intensity aerobic activity per week, which works out to about thirty minutes on five days. Brisk walking is the most accessible option for Indian women and produces measurable improvements in glucose control. A short ten-to-fifteen-minute walk after a meal helps the post-meal glucose spike fall more quickly and is one of the single highest-leverage habits to build.

Resistance training twice a week — bodyweight exercises, resistance bands or weights — builds muscle, and more muscle is metabolically protective because muscle is the largest single site of glucose disposal in the body. Many Indian women have been culturally discouraged from strength training, but it is one of the most evidence-supported additions for diabetes prevention and management at every age. Yoga has good evidence for glucose control too, particularly the asanas that involve sustained holding and the breathing practices that down-regulate stress.

Sleep matters more than is usually appreciated. Sleeping less than six hours a night, on average, measurably worsens insulin sensitivity and increases appetite-regulating hormone disturbance. Aiming for seven to nine hours of good-quality sleep is part of the diabetes plan, not a separate concern. Stress management — through deliberate routines like daily walks, meditation, time with family, hobbies and the simple act of switching off from work and phones — reduces chronic cortisol elevation that drives insulin resistance higher.

For type 1 diabetes, insulin is the only treatment and is needed from the day of diagnosis. Modern insulin regimens use a combination of long-acting basal insulin (such as glargine or detemir) once a day and short-acting bolus insulin (such as aspart or lispro) before meals, mimicking the body's natural pattern. Insulin pumps are increasingly available in Indian metros for those who want the most physiological pattern of delivery. Continuous glucose monitors paired with insulin make day-to-day management much smoother.

For type 2 diabetes, the medication ladder typically begins with metformin (Glycomet, Glucophage), which improves insulin sensitivity, modestly reduces appetite and weight, and is extremely well studied and affordable at fifty to three hundred rupees per month. If metformin alone is not enough, the next steps include sulfonylureas (glimepiride, glibenclamide), which push the pancreas to release more insulin; DPP-4 inhibitors (sitagliptin, vildagliptin), which work by extending the action of the body's own incretin hormones; SGLT-2 inhibitors (dapagliflozin, empagliflozin), which make the kidneys excrete more glucose in the urine and have important kidney-protective and heart-protective effects independent of glucose lowering; and GLP-1 receptor agonists (semaglutide, also known as Ozempic, costing around five thousand rupees or more per month), which slow gastric emptying, reduce appetite and produce substantial weight loss in many users.

Insulin is added to the type 2 regimen when oral and injectable non-insulin medications cannot maintain glucose control, when there is significant pancreatic insulin failure, during severe illness or surgery, and often during pregnancy. The decision about which medication to use and in what combination is made by the treating physician, taking into account the woman's HbA1c, kidney function, heart disease risk, weight, pregnancy status and preferences. The endocrinologist or family physician is the right person for ongoing medication adjustments, and self-stopping medication when blood sugar looks better is one of the most common mistakes that leads to rebound and complications.

Self-monitoring with a home glucometer is a core part of diabetes management. A basic glucometer costs about five hundred to fifteen hundred rupees, and strips cost three to ten rupees each in India. Type 1 diabetes usually requires several finger-prick checks a day; type 2 on oral medications often only needs occasional checks unless there are unstable readings. Continuous glucose monitors such as Freestyle Libre, which use a small skin patch that is worn for fourteen days and continuously reports glucose, cost about two thousand rupees per fortnight and have transformed the day-to-day clarity of glucose patterns for many users.

Beyond home monitoring, the standard schedule is HbA1c every three to six months, an annual dilated eye examination with an ophthalmologist (to screen for diabetic retinopathy, which can progress silently to blindness if missed), an annual foot examination (to look for early signs of neuropathy and to teach foot-care for prevention of ulcers), annual urine microalbumin and serum creatinine for kidney function, and an annual lipid profile for cardiovascular risk assessment. Blood pressure should be measured at every visit; uncontrolled hypertension multiplies the complication risk of diabetes.

The complications of poorly controlled diabetes are real and serious. Retinopathy can lead to blindness. Nephropathy can lead to dialysis. Peripheral neuropathy and foot ulcers can lead to amputation. The risk of heart attack and stroke is two to four times higher in people with diabetes. Skin infections are more frequent and more severe. Sexual dysfunction is more common. The good news is that almost all of these complications can be prevented or substantially delayed by good glucose control, blood pressure control and regular screening.

A woman with pre-existing diabetes (type 1 or type 2) who is planning a pregnancy should ideally have her HbA1c brought to below seven percent, and closer to six point five percent if achievable safely, before conception. High maternal glucose in early pregnancy substantially increases the risk of birth defects, miscarriage and large-for-gestational-age babies. Folic acid at the higher prescription dose of five milligrams per day (rather than the standard four hundred micrograms) is recommended for pre-pregnancy diabetic women to further reduce neural tube defect risk.

During pregnancy itself, glucose targets become tighter — typically fasting under ninety-five milligrams per decilitre and one-hour post-meal under one hundred and forty. Most pre-existing type 2 diabetes is shifted to insulin during pregnancy because insulin does not cross the placenta and is the most predictable and safe option, while many oral antidiabetic medications are not recommended in pregnancy. Antenatal care should be at a centre with both obstetric and endocrinology expertise, with more frequent visits than a non-diabetic pregnancy.

Gestational diabetes is high blood sugar that appears for the first time in pregnancy and is screened for by an oral glucose tolerance test at twenty-four to twenty-eight weeks. Treatment is usually diet plus monitoring first, with insulin added if glucose remains above target. After delivery, gestational diabetes resolves, but the woman carries about a fifty percent risk of developing type 2 diabetes within ten years and should have a fasting glucose or HbA1c test annually thereafter. For a full guide to gestational diabetes specifically, see Gestational Diabetes in India: OGTT Screening, Indian Diet Plan and Safe Management.